Astatine-211: Production and Availability

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|4|3|177-185

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.4, Iss.3, 2011-07, pp. : 177-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Astatine-211-Labeled Radiotherapeutics An Emerging Approach to Targeted Alpha-Particle Radiotherapy

By  

Current Pharmaceutical Design, Vol. 6, Iss. 14, 2000-09 ,pp. : 1433-1455

Bentham Science Publishers

Access to resources Recommend Favorite

[211At]Astatine-Labeled Compound Stability: Issues with Released [211At]Astatide and Development of Labeling Reagents to Increase Stability

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 144-176

Bentham Science Publishers

Access to resources Recommend Favorite

Astatine Radiopharmaceuticals: Prospects and Problems

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 177-196

Bentham Science Publishers

Access to resources Recommend Favorite

Greater availability of naloxone for heroin overdose

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 513, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Interaction of Dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system

By Striem S.   Bar-Joseph A.   Berkovitch Y.   Biegon A.  

European Journal of Pharmacology, Vol. 338, Iss. 3, 1997-11 ,pp. : 205-213

Elsevier

Access to resources Recommend Favorite